A
Emb Therapeutics Inc 110 W 118th Street Category: Biotherapeutics |
Company representatives
Virgie Bright Ellington, Chief Executive Officer
Products and Services
- Phd Biotechnology
- Ceres Biotechnology
- Recent Biotechnology
- Pharmaceutical Biotechnology
- Red Biotechnology
Location Type
Single Location
Revenue
$3,500,000 - $3,750,000
Employees
1 to 4
Years In Business
23
State of incorporation
New York
SIC code
512203 (Pharmaceutical Products-Wholesale)
NAICS code
424210 (Druggists Goods Merchant Whls)
Rating
Browse U.S. states for Biotherapeutics
